Tihomira I Todorova Selected Research

proto-oncogene protein Spi-1

1/2019	Transcriptional regulators CITED2 and PU.1 cooperate in maintaining hematopoietic stem cells.
12/2017	Pharmacological inhibition of the transcription factor PU.1 in leukemia.
10/2015	Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tihomira I Todorova Research Topics

Disease

4	Neoplasms (Cancer) 12/2021 - 10/2015
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 10/2015
2	Leukemia 11/2018 - 12/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2021
1	Bone Marrow Failure Disorders 12/2018
1	Primary Myelofibrosis (Myelosclerosis) 01/2017
1	Spinal Cord Injuries (Spinal Cord Injury) 05/2011

Drug/Important Bio-Agent (IBA)

3	proto-oncogene protein Spi-1IBA 01/2019 - 10/2015
1	CateninsIBA 12/2021
1	Trans-Activators (Trans-Acting Factor)IBA 01/2019
1	IronIBA 12/2018
1	Chelating AgentsIBA 12/2018
1	eltrombopag FDA Link 12/2018
1	Thrombopoietin ReceptorsIBA 12/2018
1	Biological ProductsIBA 11/2018
1	Interleukin-1 Receptor Accessory ProteinIBA 01/2018
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 10/2015
1	MicroRNAs (MicroRNA)IBA 05/2011

Therapy/Procedure

1	Transplantation 12/2017